Abstract
The association between acne keloidalis nuchae (AKN) and hidradenitis suppurativa (HS) is yet to be investigated. To determine the link between AKN and HS using a large computerized health maintenance database. A cross-sectional study design was used to assess the prevalence of HS in patients with AKN and in control participants matched by age, sex, and ethnicity. A total of 2677 participants with AKN and 13,190 control participants were studied. An increased prevalence of HS was observed in the AKN group compared to the control group (1.0% vs. 0.3%, respectively; OR, 3.6; 95% CI 2.2–5.8; P < 0.001), especially among those younger than 20 years (OR, 10.2; 95% CI 3.1–34.2; P < 0.001), and females (OR, 15.7; 95% CI 3.1–78.8; P < 0.001). After adjusting for confounding factors, the multivariate analysis demonstrated a persistent association of AKN with HS (adjusted OR, 3.6; 95% CI 2.1–5.9; P < 0.001). This study demonstrated a significant association between AKN and HS in an Israeli population. The threshold for diagnosis of HS among patients with AKN must be lowered in patients presenting with concerning symptoms. Further observational studies in other patient populations will help confirm this relationship.
Similar content being viewed by others
References
Dinehart SM, Herzberg AJ, Kerns BJ, Pollack SV (1989) Acne keloidalis: a review. J Dermatol Surg Oncol. 15(6):642–647
Adegbidi H, Atadokpede F, do Ango-Padonou F, Yedomon H (2005) Keloid acne of the neck: epidemiological studies over 10 years. Int J Dermatol 44(Suppl 1):49–50
Papavramidou N, Karpouzis A (2017) Early reports of “sycosis”. JAMA Dermatol. 153(3):303
Stelwagon HW (1907) Treatise on diseases of the skin: for the use of advanced students and practitioners. W.B. Saunders, Philadelphia
Sperling LC, Homoky C, Pratt L, Sau P (2000) Acne keloidalis is a form of primary scarring alopecia. Arch Dermatol 136(4):479–484
Glenn MJ, Bennett RG, Kelly AP (1995) Acne keloidalis nuchae: treatment with excision and second-intention healing. J Am Acad Dermatol 33(2 Pt 1):243–246
Halder RM (1983) Hair and scalp disorders in blacks. Cutis 32(4):378–380
East-Innis ADC, Stylianou K, Paolino A, Ho JD (2017) Acne keloidalis nuchae: risk factors and associated disorders—a retrospective study. Int J Dermatol 56(8):828–832
Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N (2018) Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis. J Investig Dermatol. 138(10):2152–2156
Garg A, Kirby JS, Lavian J, Lin G, Strunk A (2017) Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 153(8):760–764
Slade DE, Powell BW, Mortimer PS (2003) Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56(5):451–461
Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 60(4):539–561 (quiz 62–63)
Pescitelli L, Ricceri F, Prignano F (2018) Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol. 153(3 Suppl 2):8–17
Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, Mouktaroudi M, Spyridaki E, Baziaka F et al (2007) Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156(1):51–56
Vural S, Gundogdu M, Akay BN, Boyvat A, Erdem C, Kocyigit P et al (2019) Hidradenitis suppurativa: clinical characteristics and determinants of treatment efficacy. Dermatol Ther 32(5):e13003
Kanni T, Zenker O, Habel M, Riedemann N, Giamarellos-Bourboulis EJ (2018) Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? Br J Dermatol 179(2):413–419
Dauden E, Lazaro P, Aguilar MD, Blasco AJ, Suarez C, Marin I et al (2018) Recommendations for the management of comorbidity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 32(1):129–144
Shlyankevich J, Chen AJ, Kim GE, Kimball AB (2014) Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol 71(6):1144–1150
Wertenteil S, Strunk A, Garg A (2019) Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa. J Am Acad Dermatol 80(5):1308–1313
Rennert G, Peterburg Y (2001) Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 3(6):404–408
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40(5):373–383
Ogunbiyi A (2016) Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 9:483–489
Chicarilli ZN (1987) Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg 18(3):230–237
Vasanth V, Chandrashekar BS (2014) Follicular occlusion tetrad. Indian Dermatol Online J. 5(4):491–493
Shapero J, Shapero H (2011) Acne keloidalis nuchae is scar and keloid formation secondary to mechanically induced folliculitis. J Cutan Med Surg. 15(4):238–240
Lee DE, Clark AK, Shi VY (2017) Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology 233(6):456–461
De Vita V, McGonagle D (2018) Hidradenitis suppurativa as an autoinflammatory keratinization disease. J Allergy Clin Immunol. 141(5):1953
Manthiram K, Zhou Q, Aksentijevich I, Kastner DL (2017) The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol 18(8):832–842
Mozeika E, Pilmane M, Nurnberg BM, Jemec GB (2013) Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. Acta Derm Venereol 93(3):301–304
van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164(6):1292–1298
Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K et al (2011) Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol. 186(2):1228–1239
Saunte DML, Jemec GBE (2017) Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 318(20):2019–2032
Ergun T (2018) Hidradenitis suppurativa and the metabolic syndrome. Clin Dermatol 36(1):41–47
Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD (2015) Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol 173(2):464–470
Acknowledgements
IRB has exempted this study from review.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kridin, K., Patel, P.M., Jones, V.A. et al. Hidradenitis suppurativa is associated with acne keloidalis nuchae: a population-based study. Arch Dermatol Res 313, 333–337 (2021). https://doi.org/10.1007/s00403-020-02105-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-020-02105-x